Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pay-for-performance

This article was originally published in The Gray Sheet

Executive Summary

Beginning in 2012, hospitals could get an increased or decreased Medicare payment depending on how well they perform on certain standard quality measures in the treatment of heart attack, heart failure, pneumonia and surgical care, under draft legislation being circulated by the Senate Finance Committee. Chairman Max Baucus, D-Mont., and ranking member Chuck Grassley, R-Iowa, released their value-based purchasing "discussion draft" Nov. 19 and are asking for public comments on the language by Dec. 15. The legislation is intended to build on the 2003-mandated Medicare policy to adjust hospital payments based simply on whether a facility simply reports certain quality measure outcomes

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel